BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8750014)

  • 1. The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency.
    Batshaw ML; Yudkoff M; McLaughlin BA; Gorry E; Anegawa NJ; Smith IA; Hyman SL; Robinson MB
    Gene Ther; 1995 Dec; 2(10):743-9. PubMed ID: 8750014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient hyperammonemia during aging in ornithine transcarbamylase-deficient, sparse-fur mice.
    Gushiken T; Yoshimura N; Saheki T
    Biochem Int; 1985 Nov; 11(5):637-43. PubMed ID: 4091843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrations of ammonia metabolism in ornithine carbamoyltransferase-deficient spf-ash mice and their prevention by treatment with urea cycle intermediate amino acids and an ornithine aminotransferase inactivator.
    Li MX; Nakajima T; Fukushige T; Kobayashi K; Seiler N; Saheki T
    Biochim Biophys Acta; 1999 Sep; 1455(1):1-11. PubMed ID: 10524224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
    Marini JC; Erez A; Castillo L; Lee B
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1764-71. PubMed ID: 17925451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse.
    Robinson MB; Hopkins K; Batshaw ML; McLaughlin BA; Heyes MP; Oster-Granite ML
    Brain Res Dev Brain Res; 1995 Dec; 90(1-2):35-44. PubMed ID: 8777776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.
    Ye X; Robinson MB; Pabin C; Batshaw ML; Wilson JM
    Gene Ther; 2000 Oct; 7(20):1761-7. PubMed ID: 11083498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sparse fur mouse: an animal model for a human inborn error of metabolism of the urea cycle.
    Spector EB; Mazzocchi RA
    Prog Clin Biol Res; 1983; 127():85-96. PubMed ID: 6889405
    [No Abstract]   [Full Text] [Related]  

  • 8. Correction of ureagenesis after gene transfer in an animal model and after liver transplantation in humans with ornithine transcarbamylase deficiency.
    Batshaw ML; Robinson MB; Ye X; Pabin C; Daikhin Y; Burton BK; Wilson JM; Yudkoff M
    Pediatr Res; 1999 Nov; 46(5):588-93. PubMed ID: 10541323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors.
    Moscioni D; Morizono H; McCarter RJ; Stern A; Cabrera-Luque J; Hoang A; Sanmiguel J; Wu D; Bell P; Gao GP; Raper SE; Wilson JM; Batshaw ML
    Mol Ther; 2006 Jul; 14(1):25-33. PubMed ID: 16677864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of hair growth in sparse fur-abnormal skin and hair (SPF-ASH) mice by introduction of the rat ornithine transcarbamylase (OTC) gene.
    Shimada T; Tashiro M; Kanzaki T; Noda T; Murakami T; Takiguchi M; Mori M; Yamamura K; Saheki T
    J Dermatol Sci; 1994 Jul; 7 Suppl():S27-32. PubMed ID: 7999674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes.
    Morsy MA; Zhao JZ; Ngo TT; Warman AW; O'Brien WE; Graham FL; Caskey CT
    J Clin Invest; 1996 Feb; 97(3):826-32. PubMed ID: 8609240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency.
    Zimmer KP; Bendiks M; Mori M; Kominami E; Robinson MB; Ye X; Wilson JM
    Mol Med; 1999 Apr; 5(4):244-53. PubMed ID: 10448647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
    Kiwaki K; Kanegae Y; Saito I; Komaki S; Nakamura K; Miyazaki JI; Endo F; Matsuda I
    Hum Gene Ther; 1996 May; 7(7):821-30. PubMed ID: 8860834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased hyperammonaemia and orotic aciduria due to inactivation of ornithine aminotransferase in mice with a hereditary abnormal ornithine carbamoyltransferase.
    Seiler N; Grauffel C; Daune-Anglard G; Sarhan S; Knödgen B
    J Inherit Metab Dis; 1994; 17(6):691-703. PubMed ID: 7707692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of mouse ornithine transcarbamylase deficiency by gene transfer into the germ line.
    Cavard C; Grimber G; Dubois N; Chasse JF; Bennoun M; Minet-Thuriaux M; Kamoun P; Briand P
    Nucleic Acids Res; 1988 Mar; 16(5):2099-110. PubMed ID: 3162766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Variability of enzyme activity and urinary orotic acid in ornithine transcarbamylase deficient spf/+ heterozygotic mice].
    Qureshi IA; Letarte J; Lebel S; Ouellet R
    Diabete Metab; 1986 Oct; 12(5):250-5. PubMed ID: 3803679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation.
    Ahrens MJ; Berry SA; Whitley CB; Markowitz DJ; Plante RJ; Tuchman M
    Am J Med Genet; 1996 Dec; 66(3):311-5. PubMed ID: 8985493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo assessment of mutations in OTC for dominant-negative effects following rAAV2/8-mediated gene delivery to the mouse liver.
    Ginn SL; Cunningham SC; Zheng M; Spinoulas A; Carpenter KH; Alexander IE
    Gene Ther; 2009 Jun; 16(6):820-3. PubMed ID: 19357713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new family with mutation of the structural gene of human ornithine carbamoyltransferase].
    Stoll C; Bieth R; Dreyfus J; Flori E; Lutz P; Levy JM
    Arch Fr Pediatr; 1978 May; 35(5):512-8. PubMed ID: 678030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic hyperammonemia with orotic aciduria: evidence of pyrimidine pathway stimulation (author's transl)].
    Beaudry MA; Letarte J; Collu R; Leboeuf G; Ducharme JR; Melancon SB; Dallairf L
    Diabete Metab; 1975 Mar; 1():29-37. PubMed ID: 1234064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.